Table 1.

Univariate analysis of patient characteristics.

	Non-ESBL	ESBL	p-Value *
Total	112	61
Sex, male	29 (25.9%)	28 (45.9%)	0.011
Age (in years)	72.8 ± 18.8	75.8 ± 12.1	0.200
AHA-UTI	34 (30.1%)	38 (63.3%)	<0.001
Diabetes mellitus	50 (44.6%)	30 (49.2%)	0.633
Dementia	28 (25%)	13 (21.3%)	0.709
Immunosuppressive treatment	40 (35.7%)	25 (41%)	0.515
McCabe Index	2.38 ± 0.67	2.4 ± 0.64	0.105
Charlson Comorbidity Index Urinary catheterization	6.02 ± 2.7 8 (7%)	6.54 ± 2.12 10 (16.4%)	0.198 0.070
Other urinary catheters	9 (8%)	3 (4.9%)	0.543
Previous urological manipulation	16 (14.3%)	11 (18%)	0.519
Urological pathology	36 (32.1%)	22 (36.1%)	0.617
Kidney transplant	7 (6.3%)	2 (3.3%)	0.496
History of recurrent UTIs	39 (34.8%)	25 (41%)	0.510
History of pyelonephritis	16 (14.3%)	7 (11.5%)	0.648
Urinary incontinence	14 (12.5%)	14 (23%)	0.860
Previous antibiotic	38(33.9%)	39(63.9%)	<0.001
Amoxicillin/clavulanic acid	20 (17.9%)	10 (16.4%)	0.808
Trimethoprim/sulfamethoxazole	1 (0.9%)	2 (3.3%)	0.284
Quinolones	7 (6.3%)	10 (16.4%)	0.032
Fosfomycin	4 (3.6%)	3 (4.9%)	0.698
Cephalosporin	2 (1.8%)	6 (9.8%)	0.024
Carbapenems	1 (0.9%)	4 (6.6%)	0.053
Aminoglycosides	0 (0%)	1 (1.6%)	0.353
Linezolid	2 (1.8%)	1 (1.6%)	1.000
Others	1 (0.9%)	2 (3.3%)	0.284

* Student’s t-test, or Mann–Whitney U was used for comparing quantitative variables. The Chi-square test was used for comparing qualitative variables. ESBL: extended spectrum betalactamases; AHA-UTI: ambulatory Health Care-Associated Urinary Tract Infection. HCA-UTI: Health Care-Associated Urinary Tract Infection. CA-UTI: Community-Acquired Urinary Tract Infection.